Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders.
Journal: Current neurology and neuroscience reports
Published: September 11, 2023
Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-Commentary.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 02, 2022
Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies.
Journal: Multiple sclerosis and related disorders
Published: December 08, 2021
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications.
Journal: Journal of the neurological sciences
Published: February 25, 2021
Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord.
Journal: Multiple sclerosis and related disorders
Published: May 22, 2020
Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 10, 2017
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Journal: Experimental neurology
Published: March 17, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026